165 related articles for article (PubMed ID: 9304411)
1. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.
Murakami S; Ohta Y; Asami Y; Yamagishi I; Toda Y; Sato M; Tomisawa K
Gen Pharmacol; 1996 Dec; 27(8):1383-6. PubMed ID: 9304411
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
[TBL] [Abstract][Full Text] [Related]
3. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
5. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
7. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004.
Murakami S; Yamagishi I; Sato M; Tomisawa K; Nara Y; Yamori Y
Atherosclerosis; 1997 Aug; 133(1):97-104. PubMed ID: 9258412
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of acyl-CoA: cholesterol acyltransferase. II. Preparation and hypocholesterolemic activity of optically active dibenz[b,e]oxepin-11-carboxanilides.
Kumazawa T; Yanase M; Shirakura S; Ohishi E; Yamada K; Matsumiya S; Kono M
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):222-5. PubMed ID: 8582041
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
11. The ACAT inhibitor HL-004 inhibits cholesterol absorption and lowers serum cholesterol in rats.
Asami Y; Kondo Y; Murakami S; Araki H; Tsuchida K; Higuchi S
Gen Pharmacol; 1998 Oct; 31(4):593-6. PubMed ID: 9792221
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511).
Milliat F; Férézou J; Delhon A; Lutton C
C R Acad Sci III; 2001 Mar; 324(3):229-34. PubMed ID: 11291309
[TBL] [Abstract][Full Text] [Related]
13. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
[TBL] [Abstract][Full Text] [Related]
14. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
[TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats.
Murakami S; Nara Y; Yamori Y
Exp Mol Pathol; 1995 Aug; 63(1):23-32. PubMed ID: 8759051
[TBL] [Abstract][Full Text] [Related]
16. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
[TBL] [Abstract][Full Text] [Related]
17. HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.
Asami Y; Yamagishi I; Murakami S; Araki H; Tsuchida K; Higuchi S
Life Sci; 1998; 62(12):1055-63. PubMed ID: 9519807
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys.
Marzetta CA; Savoy YE; Freeman AM; Long CA; Pettini JL; Hagar RE; Inskeep PB; Davis K; Stucchi AF; Nicolosi RJ
J Lipid Res; 1994 Oct; 35(10):1829-38. PubMed ID: 7852860
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
